直接咨询 预约挂号

复大医院 > 媒体报道 > 学术书刊

癌症免疫治疗 CANCER IMMUNOTHERAPY
日期:07-01
Results analysis:
1.Immune function of tumor patients decreases gradually with the process of disease;therefore the recovery of anti-tumor ability is the inevitable way for tumor treatment.Items and are the routine evaluation indexes of "DC-CIK therapy";items and testing indexes for anti-tumor function,and the four items are used together for curative effect testing of "T cell therapy";

2.For common items,if individual index drops slightly or all indexes in the normal range,therapeutic effect is usually good;if most indexes drops slightly,multiple treatments are necessary for recovery of immune function;if most indexes drops obviously,therapeutic effect is usually bad with poor prognosis;for featured items,normal ranges are difficult to set.Before treatment,higher indexes are often associated with more powerful anti-tumor function of T cells;after treatment,rising indexes often indicate improved curative effect and better prognosis;chemotherapy and radiotherapy can affect immunotherapy significantly,and are unfavorable to treat together;

3.Ideal immune status of patient is that multiple indexes are higher beyond normal range.However,overwhlming majority of patients cannot meet this requirement when admission,so the two kinds of immune therapies adopted in our hospital are suitable for different immune status of patient.According to literature reports we have developed "T cell therapy",which can inducer large numbers of memory T cells."Tcell therapy" has srtonger ability than "DC-CIK therapy" to elevate immune indexes,and its effects can longer.

康复案例

了解更多患者康复案例

央视报道纪实

央视报道大陆纳米刀技术手术:绝境重生

CCTV4:徐克成获选冷冻学会主席

CCTV13报道:时代楷模发布厅

央视媒体报道:细妹肚里能“撑船”

专家介绍

查看我院更多专家博士

温馨提示

患者为什么选择广州复大肿瘤医院?

广州复大肿瘤医院坚持"厚德行医、医德共济"的院训,坚持"科技兴院、诚信立院、博爱办院"的办院宗旨,坚持走"高端化、学术化、国际化"道路,努力创建最具特色的国际化现代化肿瘤专科医院采用前沿抗癌理念,将世界医学难题--中晚期恶性肿瘤作为主要治疗对象,以延长患者寿命、改善患者生活质量作为主要目标。

(粤)互联网医疗审查证号:粤(A)广(2024)第995号 粤ICP备16087931号